drugset
drugset / Trial / NCT06736912

This Study Aims to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties and Food Effect of IN-114199 in Healthy Participants

NCT06736912 ↗

Phase 1 Not yet recruiting 80 enrolled HK inno.N Corporation
RandomizedSequentialTriple-blindTreatment

Summary

This study aims to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic properties and food effect of IN-114199 in healthy participants

Timeline

Start
2024-12-16
Primary completion
2025-08-30
Completion
2025-11-11

Drugs

EvaluationDrugModalityDoseRoute
Subject IN-114199 Unknown 2.5 mg Oral
Subject IN-114199 Unknown 5 mg Oral
Subject IN-114199 Unknown 10 mg Oral
Subject IN-114199 Unknown 20 mg Oral
Subject IN-114199 Unknown 40 mg Oral

Indications

constipation disorder